Dexmedetomidine and postoperative dementia risk in older patients
This study is the first to provide clinical evidence supporting dexmedetomidine's potential in reducing dementia risk, particularly ad, in older postoperative patients. Further randomised trials are needed to confirm these findings and determine the optimal use of dexmedetomidine in postoperative care. If validated, dexmedetomidine could become a critical strategy in reducing the long-term cognitive burden in ageing populations.
Authors
- Szu‐Yuan Wu (ORCID: https://orcid.org/0000-0001-5637-558X)
- Mingyang Sun (ORCID: https://orcid.org/0009-0004-8217-6508)
- Shihui Fu (ORCID: https://orcid.org/0000-0001-6707-9049)
- Wan‐Ming Chen (ORCID: https://orcid.org/0009-0009-6628-0635)
- Jiaqiang Zhang (ORCID: https://orcid.org/0000-0002-4329-784X)
- Mao Tian (ORCID: https://orcid.org/0000-0002-4418-5153)
- Wei Li (ORCID: https://orcid.org/0000-0002-7245-9772)
- Xiaojuan Xie
- Shengchun Cai (ORCID: https://orcid.org/0009-0000-2469-1633)
Institutions
- Fu Jen Catholic University (TW)
- Asia University (TW)
- Luodong Poh-Ai Hospital (TW)
- Zhengzhou University (CN)
- Henan Academy of Sciences (CN)
- Henan Provincial People's Hospital (CN)
- First Affiliated Hospital of Henan University of Science and Technology (CN)
- Wan Fang Hospital (TW)
Publication Details
- Journal
- Age and Ageing
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1093/ageing/afaf258
- Citations
- 2
- Primary Topic
- Cardiac, Anesthesia and Surgical Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.78